Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
Psychiatry Research|October 1, 1991
Lack of seasonal variation in the births of patients with dementia of the Alzheimer typeB Vitiello, J L Hill, S E Molchan, et al.Alzheimer Disease and Associated Disorders|January 1, 1997
Pharmacologic challenges in Alzheimer disease and normal controls: cognitive modeling in humansT Sunderland, S E Molchan, J T Little, et al.Acta Neurologica Scandinavica|February 1, 1995
Regional cerebral glucose metabolism in autopsy-confirmed Creutzfeldt-Jakob diseaseJ A Matochik, S E Molchan, A J Zametkin, et al.Archives of General Psychiatry|June 1, 1989
Hyperresponsivity to the serotonin agonist m-chlorophenylpiperazine in Alzheimer's disease. A controlled studyB A Lawlor, T Sunderland, A M Mellow, et al.Journal of Psychopharmacology (Oxford, England)|February 1, 2012
The effects of thyrotropin-releasing hormone and scopolamine in Alzheimer's disease and normal volunteersS E Molchan, A M Mellow, J L Hill, et al.Biological Psychiatry|October 1, 1990
Effects of daily oral m-chlorophenylpiperazine in elderly depressed patients. Initial experience with a serotonin agonistA M Mellow, B A Lawlor, T Sunderland, et al.Biological Psychiatry|July 15, 1991
A pilot placebo-controlled study of chronic m-CPP administration in Alzheimer's diseaseB A Lawlor, T Sunderland, A M Mellow, et al.Biological Psychiatry|January 1, 1997
Minimal effects of dextroamphetamine on scopolamine-induced cognitive impairments in humansR Martinez, S E Molchan, B A Lawlor, et al.Brain Research. Brain Research Reviews|September 1, 1992
Increased cognitive sensitivity to scopolamine with age and a perspective on the scopolamine modelS E Molchan, R A Martinez, J L Hill, et al.Biological Psychiatry|September 15, 1991
The TRH stimulation test in Alzheimer's disease and major depression: relationship to clinical and CSF measuresS E Molchan, B A Lawlor, J L Hill, et al.Pageof 3